Physostigmine Salicylate (Cardinal Health)


Welcome to the PulseAid listing for the Physostigmine Salicylate drug offered from Cardinal Health. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Cardinal Health
NON-PROPRIETARY NAME: Physostigmine Salicylate
SUBSTANCE NAME: PHYSOSTIGMINE SALICYLATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS:
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION
MARKETING CATEGORY NAME: UNAPPROVED DRUG OTHER
START MARKETING DATE: 2010-08-10
END MARKETING DATE: 2018-11-30


Physostigmine Salicylate HUMAN PRESCRIPTION DRUG Details:

Item DescriptionPhysostigmine Salicylate from Cardinal Health
LABELER NAME: Cardinal Health
DEA SCHEDULE:
ACTIVE STRENGTH: 1(mg/mL)
START MARKETING DATE: 2010-08-10
END MARKETING DATE: 2018-11-30
PRODUCT ID: 55154-1281_1a3e5d1d-4fd4-461c-93c7-9c51d1da96fc
PRODUCT NDC: 55154-1281
APPLICATION NUMBER:

Other PHYSOSTIGMINE SALICYLATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
AkornPhysostigmine Salicylate
Cardinal HealthPhysostigmine Salicylate